Michael Siauw's lobbying: the registrations they file and every meeting they've reported since November 2021.
← Lobbying
Registrant (responsible officer)
Michael Siauw
General Manager – Canada
For companies and organizations, the most senior paid officer files the registration and the monthly reports, whoever attended the meeting.
Meetings this Parliament
15
Since Nov 2021
24
Active registrations
1
Dec 2024 Reports per month Nov 2026
Reported meetings
Karina Gould · Member of Parliament
S-201
Bill S-201, National Framework on Sickle Cell Disease Act, respecting provisions outlined in Section 2, subsections (a), (b), (e), and (i).
Read more
Engagement on issues related to access to medicines, National Pharmacare, and a National Strategy for Drugs for Rare Diseases.
Official report
Sonia Sidhu · Member of Parliament
S-201
Bill S-201, National Framework on Sickle Cell Disease Act, respecting provisions outlined in Section 2, subsections (a), (b), (e), and (i).
Official report
Kelly DeRidder · Member of Parliament
S-201
Bill S-201, National Framework on Sickle Cell Disease Act, respecting provisions outlined in Section 2, subsections (a), (b), (e), and (i).
Official report
Juanita Nathan · Member of Parliament
Braveenan Pradeep · Legislative Assistant, House of Commons
S-201
Engagement on issues related to access to medicines, National Pharmacare, and a National Strategy for Drugs for Rare Diseases.
Read more
Bill S-201, National Framework on Sickle Cell Disease Act, respecting provisions outlined in Section 2, subsections (a), (b), (e), and (i).
Official report
Dan Mazier · Member of Parliament
Engagement on issues related to access to medicines, National Pharmacare, and a National Strategy for Drugs for Rare Diseases.
Official report
Parm Bains · Member of Parliament
Alexander MacKenzie · Legislative Assistant, House of Commons
Engagement on issues related to access to medicines, National Pharmacare, and a National Strategy for Drugs for Rare Diseases.
Official report
Tom Kmiec · Member of the House of Commons
Innovation, Science and Economic Development Canada Innovation and Skills Strategy and other government policies and programs related to incentivizing research and development activities in Canada.
Read more
Engagement on issues related to access to medicines, National Pharmacare, and a National Strategy for Drugs for Rare Diseases.
Official report
Tony Ince · Senator, Senate of Canada
Venus Ramos · Parliamentary Affairs Advisor, Senate of Canada
Engagement on issues related to access to medicines, National Pharmacare, and a National Strategy for Drugs for Rare Diseases.
Official report
Salma Zahid · Member of Parliament
Engagement on issues related to access to medicines, National Pharmacare, and a National Strategy for Drugs for Rare Diseases.
Official report
Judy A. Sgro · Member of Parliament
Engagement on issues related to access to medicines, National Pharmacare, and a National Strategy for Drugs for Rare Diseases.
Official report
Justine Frame · Policy Advisor, Health Canada (HC)
Engagement on issues related to access to medicines, National Pharmacare, and a National Strategy for Drugs for Rare Diseases.
Official report
Michael Coteau · Member of Parliament
Engagement on issues related to access to medicines, National Pharmacare, and a National Strategy for Drugs for Rare Diseases.
Official report
Sharon Burey · Senator, Senate of Canada
Engagement on issues related to access to medicines, National Pharmacare, and a National Strategy for Drugs for Rare Diseases.
Official report
Mohamed-Iqbal Ravalia · Senator, Senate of Canada
Engagement on issues related to access to medicines, National Pharmacare, and a National Strategy for Drugs for Rare Diseases.
Official report
Marie-Françoise Mégie · Senator, Senate of Canada
Suze Youance · Senator, Senate of Canada
Engagement on issues related to access to medicines, National Pharmacare, and a National Strategy for Drugs for Rare Diseases.
Official report
Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
Engagement on issues related to access to medicines, National Pharmacare, and a National Strategy for Drugs for Rare Diseases.
Official report
Mohamed-Iqbal Ravalia · Senator, Senate of Canada
Sarah Polowin · Director of Parliamentary Affairs, Senate of Canada
Health
Official report
Marie-Françoise Mégie · Senator, Senate of Canada
Nicolas Thibodeau · Parliamentary Affairs Advisor, Senate of Canada
Health
Official report
Sandenga Yeba · Senior Policy Advisor, Health Canada (HC)
Jed Graham · Policy Advisor, Health Canada (HC)
Health Research and Development Science and Technology
Official report
Daniel MacDonald · Director General, Drugs for Rare Diseases, Health Canada (HC)
Andrew Taylor · Senior Policy Advisor, Health Canada (HC)
Josee Leblanc · Senior Policy Advisor, Health Canada (HC)
Christine Ung · Policy Advisor, Health Canada (HC)
Health Research and Development Science and Technology
Official report
Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Darryl Patterson · Director General, Innovation, Science and Economic Development Canada (ISED)
Rodrigo Arancibia · Director, Innovation, Science and Economic Development Canada (ISED)
caroline menard · manager, Innovation, Science and Economic Development Canada (ISED)
Health Research and Development Science and Technology
Official report
Michael Rosu-Miles · Director, Health Canada (HC)
Aswin Hari · Biologist/Evaluator, Health Canada (HC)
Omar Tounekti · Manager, Gene Therapies Division, Health Canada (HC)
Martin Nemec · Senior Biologist/Evaluator, Health Canada (HC)
and 2 more Show fewer
Emily Griffiths · Subject Matter / Technical Specialist, Health Canada (HC)
Denis Arsenault · Manager - Policy Development, Health Canada (HC)
Health Research and Development Science and Technology
Official report
Rodrigo Arancibia · Director, Innovation, Science and Economic Development Canada (ISED)
Darryl Patterson · Director General, Innovation, Science and Economic Development Canada (ISED)
Health Research and Development Science and Technology
Official report
Benoit Leduc · Manager, Life Science Industries Directorate, Innovation, Science and Economic Development Canada (ISED)
Economic Development Health Intellectual Property Research and Development Science and Technology
Official report
From the Office of the Commissioner of Lobbying's open data , published November 5, 2026.
Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month.
Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means.
Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence .
PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.